Literature DB >> 12500224

Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery.

Wolfgang C Winkelmayer1, Raisa Levin, Jerry Avorn.   

Abstract

BACKGROUND: The aim of the study is to define the role of chronic kidney disease (CKD) as a risk factor for postoperative bleeding in patients undergoing coronary artery bypass graft (CABG) surgery.
METHODS: This is a retrospective cohort study of 238 consecutive patients who underwent isolated CABG surgery. Patients were followed up for the event of a significant bleed, defined as administration of either three or greater units of packed red blood cells, three or greater units of platelets, three or greater units of fresh frozen plasma, or any cryoprecipitate within 72 hours after a CABG procedure or undergoing a surgical revision for bleeding. Glomerular filtration rate (GFR) at baseline was calculated using the Cockroft-Gault formula. A final multiple logistic regression model was selected from a large set of presurgical and intraoperative covariates by using backward elimination (P > 0.20).
RESULTS: After controlling for age, sex, elective versus emergent surgery, intraoperative activated clotting time, serum albumin level, extracorporeal bypass time, and baseline hematocrit, we found that even mild levels of renal impairment were associated with increased risk for postoperative bleeding: patients with a GFR of 40 mL/min or less had six times the odds of postoperative bleeding than patients with a GFR greater than 100 mL/min (odds ratio [OR], 6.51; 95% confidence interval [CI], 1.87 to 22.66); those with a GFR of 41 to 60 mL/min had nearly four times the risk (OR, 3.87; 95% CI, 1.21 to 12.35). Even patients with mild CKD at a GFR of 61 to 80 mL/min were at an elevated risk (OR, 2.11); however, the 95% CI of 0.79 to 5.64 included the null value. Similar results were found when using the cruder Kidney Disease Outcomes Quality Initiative classification of CKD.
CONCLUSION: CKD is associated with risk for postoperative bleeding in patients undergoing CABG surgery, not only at more advanced stages, but probably at relatively mild levels of renal impairment, as well. Copyright 2003 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12500224     DOI: 10.1053/ajkd.2003.50026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

Review 1.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

2.  Microvascular reactivity measured by vascular occlusion test is an independent predictor for postoperative bleeding in patients undergoing cardiac surgery.

Authors:  Karam Nam; Hyung-Min Oh; Chang-Hoon Koo; Tae Kyong Kim; Youn Joung Cho; Deok Man Hong; Yunseok Jeon
Journal:  J Clin Monit Comput       Date:  2017-04-28       Impact factor: 2.502

3.  Prognostic implications of preoperative chronic kidney disease and anemia in patients undergoing coronary artery bypass graft surgery.

Authors:  Takuya Ogami; Yuya Matsue; Ryo Kawasumi; Hiroaki Tanabe
Journal:  Surg Today       Date:  2016-06-20       Impact factor: 2.549

4.  Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis.

Authors:  Gloria Färber; Sabine Bleiziffer; Torsten Doenst; Dimitra Bon; Andreas Böning; Helge Weiler; Eva Herrmann; Christian Frerker; Andreas Beckmann; Helge Möllmann; Stephan Ensminger; Raffi Bekeredjian; Thomas Walther; Wolfgang Harringer; Hugo A Katus; Christian W Hamm; Friedhelm Beyersdorf; Timm Bauer; Stephan Fichtlscherer
Journal:  Clin Res Cardiol       Date:  2020-09-23       Impact factor: 5.460

5.  Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Morgan E Grams; Rakhi P Naik; Josef Coresh; Kunihiro Matsushita
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

6.  Renal dysfunction is an independent risk factor for bleeding after gastric ESD.

Authors:  Teppei Yoshioka; Tsutomu Nishida; Masahiko Tsujii; Motohiko Kato; Yoshito Hayashi; Masato Komori; Harumasa Yoshihara; Takeshi Nakamura; Satoshi Egawa; Toshiyuki Yoshio; Takuya Yamada; Takamasa Yabuta; Katsumi Yamamoto; Kazuo Kinoshita; Naoki Kawai; Hideharu Ogiyama; Akihiro Nishihara; Tomoki Michida; Hideki Iijima; Ayumi Shintani; Tetsuo Takehara
Journal:  Endosc Int Open       Date:  2014-10-29

7.  A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

Authors:  Hideyuki Akaza; Mototsugu Oya; Masafumi Iijima; Ichinosuke Hyodo; Akihiko Gemma; Hiroshi Itoh; Masatoshi Adachi; Yutaka Okayama; Toshiyuki Sunaya; Lyo Inuyama
Journal:  Jpn J Clin Oncol       Date:  2015-07-22       Impact factor: 3.019

8.  Unexplained occurrence of multiple de novo pseudoaneurysms in patients with chronic kidney disease undergoing angioembolization for bleeding following percutaneous renal intervention: Are we dealing with infection or vasculitis?

Authors:  Debansu Sarkar; Anupam Lal; Mayank M Agarwal; Ravimohan S Mavuduru; Santosh Kumar; Shrawan K Singh
Journal:  Indian J Urol       Date:  2013-04

9.  Upper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan.

Authors:  Chih-Chia Liang; Che-Yi Chou; Chiz-Tzung Chang; I-Kuan Wang; Chiu-Ching Huang
Journal:  BMJ Open       Date:  2016-05-05       Impact factor: 2.692

10.  Prognostic factors and clinical outcomes of acute intracerebral hemorrhage in patients with chronic kidney disease.

Authors:  Jin Kyu Kim; Jun Jae Shin; Sang Keun Park; Yong Soon Hwang; Tae Hong Kim; Hyung Shik Shin
Journal:  J Korean Neurosurg Soc       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.